Literature DB >> 23769985

Let7a inhibits the growth of endometrial carcinoma cells by targeting Aurora-B.

Ping Liu1, Meiyan Qi, Chengbin Ma, Guoying Lao, Yu Liu, Yan Liu, Yingzi Liu.   

Abstract

MicroRNAs negatively regulate target gene expression at the post-transcriptional level during carcinogenesis. Recent advances revealed that the expression levels of several miRNAs are up- or down-regulated in endometrial carcinoma (EC). Here we identify dysregulated miRNAs in EC and we elucidate the essential role of let-7a. The expression of 86 miRNAs in EC was found to be different from adjacent normal endometrial tissues. Moreover, miR-let-7 members are down-regulated in EC and let-7 miRNAs are highly associated with endometrial cancer. A functional investigation revealed that let-7a suppressed proliferation of HeLa cells by targeting Aurora-B. Let-7a also antagonizes Aurora-B functions in promoting carcinoma cell proliferation by down-regulating Aurora-B protein level. Let-7a could be applied for gene therapy against endometrial carcinogenesis.
Copyright © 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Endometrial carcinoma cell; Let-7a; MicroRNA; Targeting Aurora-B

Mesh:

Substances:

Year:  2013        PMID: 23769985     DOI: 10.1016/j.febslet.2013.05.065

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  MicroRNA let-7b regulates genomic balance by targeting Aurora B kinase.

Authors:  Jenni Heidi Eveliina Mäki-Jouppila; Sofia Pruikkonen; Mahesh Balasaheb Tambe; Miriam Ragle Aure; Tuuli Halonen; Anna-Leena Salmela; Leena Laine; Anne-Lise Børresen-Dale; Marko Johannes Kallio
Journal:  Mol Oncol       Date:  2015-01-27       Impact factor: 6.603

Review 2.  MicroRNAs in gynecological cancers: Small molecules with big implications.

Authors:  Sanjeev K Srivastava; Aamir Ahmad; Haseeb Zubair; Orlandric Miree; Seema Singh; Rodney P Rocconi; Jennifer Scalici; Ajay P Singh
Journal:  Cancer Lett       Date:  2017-05-24       Impact factor: 8.679

3.  miR-let-7c-3p targeting on Egr-1 contributes to the committed differentiation of leukemia cells into monocyte/macrophages.

Authors:  Fu Qi; Xinping Wang; Shouzhen Zhao; Chaozhe Wang; Ruijing Sun; Huan Wang; Pengchao Du; Jing Wang; Xidi Wang; Guosheng Jiang
Journal:  Oncol Lett       Date:  2022-06-22       Impact factor: 3.111

Review 4.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

5.  miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer.

Authors:  Noushin Nabavi; Nur Ridzwan Nur Saidy; Erik Venalainen; Anne Haegert; Abhijit Parolia; Hui Xue; Yuwei Wang; Rebecca Wu; Xin Dong; Colin Collins; Francesco Crea; Yuzhuo Wang
Journal:  Sci Rep       Date:  2017-06-22       Impact factor: 4.379

Review 6.  Role of let-7 family microRNA in breast cancer.

Authors:  Chadrashekar Kagepura Thammaiah; Shankar Jayaram
Journal:  Noncoding RNA Res       Date:  2016-11-04

7.  E-cadherin Interacts With Posttranslationally-Modified AGO2 to Enhance miRISC Activity.

Authors:  Jie-Ning Li; Hui-Lung Sun; Ming-Yang Wang; Pai-Sheng Chen
Journal:  Front Cell Dev Biol       Date:  2021-07-05

Review 8.  MicroRNAS in endometrial cancer: recent advances and potential clinical applications.

Authors:  Megumi Yanokura; Kouji Banno; Miho Iida; Haruko Irie; Kiyoko Umene; Kenta Masuda; Yusuke Kobayashi; Eiichiro Tominaga; Daisuke Aoki
Journal:  EXCLI J       Date:  2015-02-02       Impact factor: 4.068

Review 9.  MicroRNAs: novel players in cancer diagnosis and therapies.

Authors:  Aaron L Oom; Brock A Humphries; Chengfeng Yang
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

10.  Aurora kinase targeting in lung cancer reduces KRAS-induced transformation.

Authors:  Edmilson Ozorio Dos Santos; Tatiana Correa Carneiro-Lobo; Mateus Nobrega Aoki; Elena Levantini; Daniela Sanchez Bassères
Journal:  Mol Cancer       Date:  2016-02-03       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.